199 related articles for article (PubMed ID: 29212101)
21. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
22. Participation in colorectal cancer screening trials after first-time invitation: a systematic review.
Khalid-de Bakker C; Jonkers D; Smits K; Mesters I; Masclee A; Stockbrügger R
Endoscopy; 2011 Dec; 43(12):1059-86. PubMed ID: 22135196
[TBL] [Abstract][Full Text] [Related]
23. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study.
Lisi D; Hassan C; Crespi M;
Dig Liver Dis; 2010 May; 42(5):371-6. PubMed ID: 19747888
[TBL] [Abstract][Full Text] [Related]
24. Patient-Initiated Colonoscopy Scheduling Effectively Increases Colorectal Cancer Screening Adherence.
Mankaney G; Rizk M; Sarvepalli S; Bongorno J; Garber A; Lopez R; McMichael J; Burke CA
Dig Dis Sci; 2019 Sep; 64(9):2497-2504. PubMed ID: 30877609
[TBL] [Abstract][Full Text] [Related]
25. [Current evidence and development of colorectal cancer screening in Germany].
Haug U
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1513-1516. PubMed ID: 30327833
[TBL] [Abstract][Full Text] [Related]
26. Organized colorectal cancer screening in Serbia - the first round within 2013-2014.
Banković Lazarević D; Krivokapić Z; Barišić G; Jovanović V; Ilić D; Veljković M
Vojnosanit Pregl; 2016 Apr; 73(4):360-7. PubMed ID: 29309104
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial.
Selva A; Torà N; Pascual E; Espinàs JA; Baré M
Colorectal Dis; 2019 Oct; 21(10):1120-1129. PubMed ID: 31099455
[TBL] [Abstract][Full Text] [Related]
28. Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.
Senore C; Ederle A; DePretis G; Magnani C; Canuti D; Deandrea S; Zorzi M; Barca A; Bestagini P; Faitini K; Bisanti L; Casale C; Ferro A; GiorgiRossi P; Quadrino F; Fiorina G; Capuano A; Segnan N; Fantin A
Prev Med; 2015 Apr; 73():106-11. PubMed ID: 25602908
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing participation in colorectal cancer screening programs in Spain.
Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
[TBL] [Abstract][Full Text] [Related]
30. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
[TBL] [Abstract][Full Text] [Related]
31. Influences on participation in a community-based colorectal neoplasia screening program by virtual colonoscopy in Australia.
Forbes GM; Fritschi L; Mendelson RM; Foster NM; Edwards JT
Aust N Z J Public Health; 2004 Jun; 28(3):283-7. PubMed ID: 15707176
[TBL] [Abstract][Full Text] [Related]
32. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
33. Initial participation as a predictor for continuous participation in population-based colorectal cancer screening.
Saraste D; Öhman DJ; Sventelius M; Elfström KM; Blom J; Törnberg S
J Med Screen; 2018 Sep; 25(3):126-133. PubMed ID: 28786766
[TBL] [Abstract][Full Text] [Related]
34. Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY study.
Radde K; Gottschalk A; Bussas U; Schülein S; Schriefer D; Seifert U; Neumann A; Kaiser M; Blettner M; Klug SJ
Int J Cancer; 2016 Sep; 139(5):1018-30. PubMed ID: 27083776
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
36. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
37. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].
Rutka M; Molnár T; Bor R; Farkas K; Fábián A; Győrfi M; Bálint A; Milassin Á; Szűcs M; Tiszlavicz L; Nagy F; Szepes Z
Orv Hetil; 2017 Oct; 158(42):1658-1667. PubMed ID: 29037058
[TBL] [Abstract][Full Text] [Related]
39. Colon capsule versus computed tomography colonography for colorectal cancer screening in patients with positive fecal occult blood test who refuse colonoscopy: a randomized trial.
Pioche M; Ganne C; Gincul R; De Leusse A; Marsot J; Balique J; Fond A; Bretagnolle M; Henry L; Billaud Y; Malezieux R; Lapalus MG; Chambon-Augoyard C; Del Tedesco E; Scalone O; Montoy JC; Russias B; Detry A; Veniat F; Qiu J; Valette PJ; Taillandier A; Saurin JC; Tomczyk-Ferrero J; Gandilhon C; Vecchiato L; Soler-Michel P; Ponchon T
Endoscopy; 2018 Aug; 50(8):761-769. PubMed ID: 29486502
[TBL] [Abstract][Full Text] [Related]
40. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
